aBSTRACT author Index 342 Nuzzo, A 581 Nyengaard, JR 1485 Nygaard, H 1774 Nys, M 1407 Nytrova, P 1174 Nzeusseu Toukap, A 2263 O Oates, J 437, 622, 1403, 2123, 2125 Oatis, CA 684, 2053, 2054, 2136 Oba, T 1814, 1815 Obayashi, H 1511 O’Brien, A 989, 2112 O’Brien, W 148, 883 O’Colmain, BJ 2062 O’Connor, CR 885 O’Connor, P 1929 Odai, T 1773 Odani, T 2, 1909 Odden, AJ 402 Oddis, CV 913, 925, 929, 930, 1212, 1379 Odeh, M 550 O’Dell, JR 77, 299, 658, 1094, 1368, 2235 Oderkirk, J 1555 Odom, J 1161 O’Donnell, CI 1083 O’Donnell, JL 417 O’Donnell, S 1562 Oelke, KR 383 Oen, KG 214 Oerum, H 1529 Oeser, A 1023, 1034, 1607, 1867, 2123 Oess, S 2275 Offutt, C 1122 Ogale, S 68, 338, 1882 Ogden, L 1311 Ogdie, A 1554 O’Grady, M 817, 818 Oh, C 707, 708 Oh, J 366, 372, 876, 1297, 2158 Oh, TH 104, 108 Oh, U 1161 Ohinmaa, A 330 Ohlsson, B 1902 Ohmura, K 1377 Ohno, S 139, 480, 1081, 2217 Ohrndorf, S 1621, 1634 Ohta, A 433 Ohta, H 1839 Ohta, K 652 Ohta, S 1115 Ohtsuka, K 26 Oishi, H 351 2010 Program Book Okada, A 364, 1371, 1632 Okada, J 568 Okada, M 1783 Okada, Y 1577 Okamoto, Y 447, 746, 897, 916, 923, 1184, 1587, 1844 Okano, T 981 Okawa, J 920 Okiyama, N 1375 Oku, K 10, 2254 Okuda, K 1138, 1738, 1739 Okura, Y 1672 Olds, M 1930, 1935 O’Leary, D 1148, 2163 Olech, E 101, 120, 125, 414 Olenginski, TP 999 Olferiev, M 508, 1183 Olivé, A 1741 Oliveira, A 1507, 1519 Oliveira, SK 210 Oliveira Sato, J 1872 Olivier, B 922 Olivieri, I 532 Olsen, NJ 1188, 1491 Olson, AK 828 Olsson, L 825 Olsson, T 832 Ombrello, A 1698, 2105 Ombrello, MJ 1281, 2217 Omdal, R 1579, 1885, 1913 O’Meara, M 1095 Ometto, F 290 Onat, AM 1921 Onat, D 1183 One Thousand Faces <strong>of</strong> Lupus 1864 O’Neil, KM 1673, 1690, 1691, 1701, 2017 O’Neill, L 16, 2111 Onel, K 464, 1701 Onen, F 544, 666, 1282, 1283, 1921 Ong, V 590, 1996 Ono, Y 1285 Oomae, T 298 Oortwijn, A 2270 Opava, CH 2245 Oph<strong>of</strong>f, RA 2214 Opitz, CF 599 Oppermann, BP 977 Optimising Patient Outcomes in Australian RheumatoLogy [OPAL] Consortium 319 Orange, D 863 Oranje, AP 219 Orcel, P 413 Oreiro, N 835 Oreiro-Villar, N 541, 1920 Oribe, M 1138 Orie, NN 2005 Origuchi, T 1371, 1632 Orlov-Morozov, A 1125 Ormseth, MJ 1034 Ørnbjerg, LM 1444, 1841 Oro, S 2238 Orozco, G 1075 Orozco, J 1407 Ortego-Centeno, N 824, 829, 1301, 2214 Ortel, T 6 Ortiz, AM 516, 1505 Ortiz, MA 1801 Ortmann, W 1608 Orzechowski, NM 595 Osban, J 247, 655 Osborne, R 204, 1001, 1009, 2079, 2139 Osgood, KG 1395 O’Shea, FD 512 Oshikawa, H 1641 Osman, M 816 Ospelt, C 21, 1093, 1528 Ossanna, MJ 175 Östberg, T 832 Østergaard, M 132, 133, 134, 141, 1097, 1114, 1369, 1370, 1444, 1809, 1841, 1953, 2264 Ostendorf, B 138, 1615 Osterroth, F 1125 Osting, V 44 Ostor, A 395, 1840 Ostrov, BE 1002 O’Sullivan, B 1116 O’Sullivan, J 360, 1510 Ota, T 1086 Ota, Y 447, 746, 897, 916, 923, 1184, 1587, 1666 Otomo, K 2, 5, 10, 1909, 2254 Otsuka, K 1773 Otsuki, S 369 Otten, MH 219, 1872 Ottery, F 157, 166 Ou, J-N 506 Oudiz, R 598 Ouellet-Hellstrom, R 54 Outman, RC 1005, 1006, 1543, 1561 Ouyang, W 715 Owada, T 472 Owen, S-A 1394 Owen, T 436 Owens, EK 17 Oyoo, OG 1336 Ozaki, S 365 Ozdemir, B 114 Ozdemir, FT 2200 Ozdogan, H 1279, 1684, 1697 Ozen, S 905, 1305, 1705 Ozguler, Y 1697 Ozturk, MA 1921 Ozyazgan, Y 1288, 1312, 1697 P Pablos, JL 20, 482, 1078 Paccou, J 904 Pachman, LM 242, 826, 928, 1686 Packham, J 264, 266, 664, 833 Padovan, M 1162 Padykov, L 2214 Padyukov, L 832, 2118 Paessler, M 1354 Page, GG 949 Paget, SA 43 Pagnier, A 1693 Pagnini, I 240, 1675 Pagnoux, C 2009, 2014, 2026, 2034, 2041, 2043, 2045 Paikos, S 1897 Paintaud, G 988, 1945 Paira, S 50 Pajewski, NM 1591 Pajot, C 1305 Pak, CH 178 Pal, HK 1925 Palacios, S 971 Palanichamy, A 1085 Palau, J 2223 Palazzo, JP 1907 Palframan, R 1245 Pallares, L 1888 Palm, O 1275 Palmer, E 486, 733 Palmer, G 1490 Palmer, RH 98, 806 Palmisani, E 207 Pals, ST 1711 Palter, J 1702 Palumbo, K 607, 611, 614, 615, 616, 672 Pamer, E 1390 Pan, S 1242, 1598 Pan, W-H 2088 Pan, Z-j 1267 Panagiotakos, DB 1897 Panayi, GS 1729 Pandya, B 878, 879, 1363, 1547, 2154 Panepento, B 521, 849 Pangan, A 518, 559, 1949 Panghaal, V 1630 Panicker, S 1270 Pannier, E 2034 Panopalis, P 107, 789, 2113
Pans, M 1834 Parra, ER 605, 887 Peda, MA 901 Perry, M 562, 725 Paolini, C 2001 Parsa, MF 998 Pedersen, R 514, 1927, 1937 Pers, J-O 737, 1914, 2177 Pap, T 368, 1130, 1478, 1486, 1719, 2237 Papadopoulos, N 1021 Papageorgiou, A 1912 Papagoras, C 1215 Papalardo, E 1361, 2251, 2252, 2253 Papapoulos, S 2157 Papo, T 2239 Pappa, C 1395 Pappas, DA 45, 1022, 1799 Pappas, J 150 Pappas, T 1536 Pappu, R 390, 1834, 2173 Paradisi, M 1439 Paragh, G 519 Paramarta, J 1977, 2272 Parambil, J 564, 592 Paran, D 697, 1159, 1238 Pardeo, M 209, 2033 Pardo, P 144, 1154 Parimi, N 624 Parish, M 1094 Park, E-J 366, 372, 1297 Park, GS 1103, 1117 Park, HS 1716 Park, JK 677, 681, 919, 2167 Park, JL 255 Park, JA 1751 Park, JS 842 Park, K 2225 Park, KS 353, 370, 756, 1716, 1770 Park, KU 1523 Park, M-C 27, 1061, 1873, 387 Park, MJ 1716 Park, M-K 353 Park, R 1499 Park, S 84, 276 Park, S-H 277, 323, 353, 370, 756, 903, 1209, 1716, 1770 Park, S-Y 1585 Park, W 1813 Park, Y 276 Park, Y-B 27, 387, 1061, 1873, 2028 Park, Y-E 277, 1209 Park, Y-W 116, 505, 1891 Parker, B 1177 Parker, J 1207 Parks, C 61, 1062 Parks, EL 2097 Parks, M 1576 Parmar, K 42 Parmar, R 1090, 1126, 1254 Parolin, M 1682 Parsons, L 1223 Parvu, M 405, 848 Paschides, CA 1215 Pasco, J 183 Pascoli, L 240 Pascual-Ramos, V 337, 1881 Pascual-Salcedo, D 1599 Pasic, S 1684, 1705 Pasoto, SG 481 Passarelli, M 887 Pasternak, R 1119 Pastrak, A 285 Patel, A 1740 Patel, DD 19, 1487 Patel, DR 1253 Patel, J 1477 Patel, N 895, 1425 Patel, RK 1430 Patel, S 126 Patel, V 288, 1270 Patel, Z 1531 Paternotte, S 63, 529, 948, 1648, 1924 Paterson, JM 57, 313, 341 Patil, S 456 Patkar, NM 304, 404, 722, 1573, 1643, 2103 Patra, K 123, 1101, 1102, 1108, 1113, 1791 Patrizi, A 1439 Patschan, D 2021 Patschan, S 2021 Patternotte, S 1104 Patterson, N 153 Pau, E 424, 425, 429 Paul, B 620, 1399 Pauley, KM 2174 Paulo, LTP 1339 Paulus, H 155, 299, 583, 1058, 1365, 1368, 1779, 1789 Pauly, T 368 Pavelka, K 55, 638, 971, 1802, 1807, 1840 Pavenstädt, H 2237 Pavletic, S 1161 Pavy, S 548 Pawar, R 2186 Paxton, LA 1620 Payeli, SK 1973 Payet, J 529, 1924 Payne, AJ 1030 Payoux, P 2027 Paz, E 1407 Pearce, W 1168 Pease, C 777, 1637, 1652, 1654 Pecchi, E 37 Pedersen, SJ 134, 1953 Pedersen, TK 1687 Pedriger, A 1910 Pedro, S 89 Peeters, AJ 1396 Peeva, V 13, 1156, 2120 Peffer, N 1968 Peh, CA 676 Peikert, T 680 Peinado, V 1070 Peiro, M 1296 Peiro Callizo, ME 1650 Pelajo, CF 231 Pelck, R 1444, 1841 Peliçari, K 1695 Pelletier, J-P 196, 938, 1489, 1497 Pellett, F 530, 1966, 1974, 1975, 1979, 1984 Peloquin, C 2067, 2212, 2213 Peluso, G 355, 744, 1098, 1582 Pemberton, P 1067 Peña Salgredo, JL 1650 Peña-Arrébola, A 2268 Penadés, IC 1407 Penco, F 265 Pendl, J 218, 268, 2106 Peng, SL 901 Peng, Y 1843, 1919 Penney, CJ 330 Pennington, LF 748 Penya, J 1137 Pepe, P 811, 1916 Peracchi, OAB 1676 Perard, L 2239 Perdriger, A 63, 701, 1890 Pereira, K 356, 498, 504, 1695 Pereira, RM 1384, 1437, 1546, 2078, 2134 Pereira Da Silva, JA 1013 Perell-Gerson, KL 169 Perez, E 1801 Perez, MD 1678 Perez-Alvarez, R 1888 Perez-Pampin, E 1076, 1078 Perez-Ruiz, F 159, 873, 151, 882, 1572 Perez-Sanchez, C 1357 Pericleous, C 1358, 1359 Perilongo, G 1439 Perino, G 427 Perl, A 437, 449, 1185, 1196, 2275 Perlman, H 853, 854, 859, 861, 1723 Perrella, O 2201 Perrot, S 97 Persad, P 2077 Persselin, J 155, 1365 Pértega, S 835 Pertega-Diaz, S 541, 1920 Peschken, C 448, 476, 731, 1176, 1674, 1850, 1852, 1864, 1877, 2240, 2243 Petchprapa, C 708 Peter, WFH 2051 Peterfy, C 120, 123, 125, 1369, 1817 Peters, C 1243, 1245 Peters, MA 368, 1719 Peters, MJL 90, 643, 1029, 2211 Peterson, D 156, 322, 791 Peterson, EJ 934 Peterson, LK 748, 2128 Peterson, MGE 1872 Petersson, I 761, 963, 1392, 1393, 2209 Petri, M 14, 268, 445, 448, 452, 453, 454, 460, 473, 474, 476, 479, 485, 487, 731, 733, 765, 1148, 1149, 1163, 1180, 1403, 1452, 1454, 1456, 1457, 1591, 1592, 1594, 1608, 1848, 1858, 1877, 1879, 2121, 2122, 2124, 2149, 2162, 2240, 2243, 2260 Petrich, J 574 Petronis, J 1887 Petterson, S 1846 Pettersson, E 1381 Pettersson, T 891 Pettijohn, K 509 Pettinger, M 1062 Pettit, A 2184 Petty, RE 1674 Pezic, A 248 Pfaefflin, A 770 Pfeffer, S 858 Pham, T 260, 1752, 1810, 1831, 2269 PHAROS Investigators 561, 569, 570, 586, 591, 729 Phaujdar, S 1925 Phelps, D 1395 Philippe, L 858 Philippet, P 1700 Phillips, CR 62 Phillips, K 402, 567, 585, 1212, 1222, 2007, 2073 Phillips, PE 1185, 1196 Piatti, A 1854, 1855 Pickard, L 969 Pickens, SR 23, 270, 714, 1506 Piera, S 2007 Pierangeli, S 3, 6, 12, 1360, 1361, 2250, 2251, 2252, 2253, 2255 2010 Program Book 343 abstract author Index
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS ACCREDITATION . .
- Page 7 and 8:
TABLE OF CONTENTS ACR/ARHP Poster S
- Page 9 and 10:
TABLE OF CONTENTS Systemic Sclerosi
- Page 11 and 12:
the written consent of the ACR is p
- Page 13 and 14:
Shuttle Bus Service See shuttle sig
- Page 15 and 16:
ACR Resource Center Hours: Sunday,
- Page 17 and 18:
ACR Hotels + Map Complimentary shut
- Page 19 and 20:
to the premier meeting in rheumatol
- Page 21 and 22:
ACR Clinical Research Conference c/
- Page 23 and 24:
4:20 PM Germinal Center Reactions A
- Page 25 and 26:
3:30 PM Live Demonstration: Ultraso
- Page 27 and 28:
Upon completion of this session, pa
- Page 29 and 30:
MONDAY, NOVEMBER 8, 2010 ACR/ARHP R
- Page 31 and 32:
B301 Dermatological Manifestations
- Page 33 and 34:
Session Overview: The innate immune
- Page 35 and 36:
Upon completion of this session, pa
- Page 37 and 38:
B308 Inflammatory Eye Disease P/C M
- Page 39 and 40:
and insufficiency • recall source
- Page 41 and 42:
Session Overview: The advent of bio
- Page 43 and 44:
2:45 pm 641. Major Improvements in
- Page 45 and 46:
5 University of Twente and Medisch
- Page 47 and 48:
ACR/ARHP Combined Abstract Session
- Page 49 and 50:
REF 25th Anniversary Celebration 2:
- Page 51 and 52:
5:45 PM 699. Defining Latent and/or
- Page 53 and 54:
Lilian H. D. van Tuyl 8 , Karin Bri
- Page 55 and 56:
ACR REF Special Sessions 4:30 - 6:0
- Page 57 and 58:
REF 5K Run/Walk 6:00 - 8:00 am See
- Page 59 and 60:
• discuss the principles of early
- Page 61 and 62:
ACR Medical Aspects of Rheumatic Di
- Page 63 and 64:
10:00 am 1349. Work as a Daily Chal
- Page 65 and 66:
ACR Plenary Session II: Discovery 2
- Page 67 and 68:
B210 B301 Pediatrics: Periodic Feve
- Page 69 and 70:
Session Overview: As a clinical edu
- Page 71 and 72:
Thomas J. Murphy Ballroom Giant Cel
- Page 73 and 74:
3:45 PM 1367. Serum Urate Levels in
- Page 75 and 76:
A411 Rheumatoid Arthritis - Human E
- Page 77 and 78:
2:45 PM 1405. Development of a Visi
- Page 79 and 80:
4:30 PM Anti-citrullinated Protein
- Page 81 and 82:
of Experimental Orthopedics, Univer
- Page 83 and 84:
5:30 PM 1438. Mortality/Morbidity i
- Page 85 and 86:
5:30 PM 1456. Belimumab, a BLyS-Spe
- Page 87 and 88:
Develly 5 , Bernardo L. F. Fernande
- Page 89 and 90:
7:30 PM Role of IL-1 in Human Artic
- Page 91 and 92:
• compare the prevalence and epid
- Page 93 and 94:
6:45 PM Macrophage Activation Syndr
- Page 95 and 96:
Upon completion of this session, pa
- Page 97 and 98:
Session Overview: This roundtable d
- Page 99 and 100:
B303 Scleroderma: Systemic Sclerosi
- Page 101 and 102:
9:00 - 10:30 am - Poster Hall Morni
- Page 103 and 104:
• describe the role of IL-1 and I
- Page 105 and 106:
Session Overview: For the clinician
- Page 107 and 108:
• identify the aspects for day-to
- Page 109 and 110:
ACR Study Groups 1:00 - 2:00 PM B30
- Page 111 and 112:
Session Overview: Ultrasound and ma
- Page 113 and 114:
Session Overview: Fifty percent of
- Page 115 and 116:
1:20 PM Academic Rheumatology Seth
- Page 117 and 118:
ACR Concurrent Abstract Sessions 2:
- Page 119 and 120:
3:00 PM 2110. Rheumatologists on th
- Page 121 and 122:
2:45 PM 2133. Reasons for Decline i
- Page 123 and 124:
Session Overview: We are witnessing
- Page 125 and 126:
Session Overview: Systemic sclerosi
- Page 127 and 128:
Oaks, CA, 2 Amgen Inc., San Francis
- Page 129 and 130:
5:00 PM 2176. A Role of Autoimmune
- Page 131 and 132:
4:30 PM 2198. Association between V
- Page 133 and 134:
ARHP Concurrent Sessions 4:30 - 6:0
- Page 135 and 136:
THURSDAY, NOVEMBER 11, 2010 ACR/ARH
- Page 137 and 138:
• apply these basic statistics to
- Page 139 and 140:
9:15 AM The ACR/EULAR Definition of
- Page 141 and 142:
Immunology, Oslo University Hospita
- Page 143 and 144:
9:15 AM 2239. Factors Associated wi
- Page 145 and 146:
Upon completion of this session, pa
- Page 147 and 148:
Mikkel Østergaard 6 , Paul Emery 4
- Page 149 and 150:
Ende 4 , 1 Department of Rheumatolo
- Page 151 and 152:
ACR Poster Session A Cytokines, Med
- Page 153 and 154:
ACR Poster Session A 51. Associatio
- Page 155 and 156:
ACR Poster Session A 83. Respirator
- Page 157 and 158:
ACR Poster Session A 121. Bone Dens
- Page 159 and 160:
ACR Poster Session A 142. The Intra
- Page 161 and 162:
ACR Poster Session A 171. Early Pro
- Page 163 and 164:
ACR Poster Session A Pediatric Rheu
- Page 165 and 166:
ACR Poster Session A 233. Prevalenc
- Page 167 and 168:
ACR Poster Session A 266. Subtype S
- Page 169 and 170:
ACR Poster Session A 297. Body Weig
- Page 171 and 172:
ACR Poster Session A 325. Patient R
- Page 173 and 174:
ACR Poster Session A 356. Influence
- Page 175 and 176:
ACR Poster Session A 383. Efficacy
- Page 177 and 178:
ACR Poster Session A 409. Rituximab
- Page 179 and 180:
ACR Poster Session A 441. Recombina
- Page 181 and 182:
ACR Poster Session A 465. Immunoglo
- Page 183 and 184:
ACR Poster Session A 496. IRF8 Alle
- Page 185 and 186:
ACR Poster Session A 521. DC-STAMP
- Page 187 and 188:
ACR Poster Session A 546. Prevalenc
- Page 189 and 190:
ACR Poster Session A 571. Epidemiol
- Page 191 and 192:
ACR Poster Session A 599. Validatio
- Page 193 and 194:
ACR/ARHP Poster Session B Halls B1
- Page 195 and 196:
ACR Poster Session B 767. Economic
- Page 197 and 198:
ACR/ARHP Poster Session B 792. The
- Page 199 and 200:
ACR/ARHP Poster Session B Universit
- Page 201 and 202:
ACR/ARHP Poster Session B 848. Cell
- Page 203 and 204:
ACR/ARHP Poster Session B 886. Scre
- Page 205 and 206:
ACR/ARHP Poster Session B 909. Regu
- Page 207 and 208:
ACR/ARHP Poster Session B 935. The
- Page 209 and 210:
ACR/ARHP Poster Session B 967. Frac
- Page 211 and 212:
ACR Poster Session B 993. Early Exp
- Page 213 and 214:
ACR/ARHP Poster Session B 1022. Com
- Page 215 and 216:
ACR/ARHP Poster Session B 1055. Son
- Page 217 and 218:
ACR Poster Session B 1084. Gene Exp
- Page 219 and 220:
ACR/ARHP Poster Session B 1111. Inc
- Page 221 and 222:
ACR Poster Session B hiroshima Memo
- Page 223 and 224:
ACR/ARHP Poster Session B 1166. Pre
- Page 225 and 226:
ACR/ARHP Poster Session B 1199. Typ
- Page 227 and 228:
ACR/ARHP Poster Session B 1225. Phy
- Page 229 and 230:
ACR/ARHP Poster Session B 1262. Lat
- Page 231 and 232:
ACR/ARHP Poster Session B 1294. End
- Page 233 and 234:
ACR/ARHP Poster Session B 1321. Cha
- Page 235 and 236:
ACR/ARHP Poster Session C Halls B1
- Page 237 and 238:
ACR/ARHP Poster Session C 1495. S10
- Page 239 and 240:
ACR/ARHP Poster Session C 1524. Inc
- Page 241 and 242:
ACR/ARHP Poster Session C 1555. Pro
- Page 243 and 244:
ACR/ARHP Poster Session C 1583. Ass
- Page 245 and 246:
ACR/ARHP Poster Session C 1596. Gen
- Page 247 and 248:
ACR/ARHP Poster Session C 1622. Flu
- Page 249 and 250:
ACR/ARHP Poster Session C Miscellan
- Page 251 and 252:
ACR/ARHP Poster Session C L. Woodwa
- Page 253 and 254:
ACR/ARHP Poster Session C 1692. Res
- Page 255 and 256:
ACR/ARHP Poster Session C 1719. Los
- Page 257 and 258:
ACR/ARHP Poster Session C 1749. Con
- Page 259 and 260:
ACR/ARHP Poster Session C 1780. Tow
- Page 261 and 262:
ACR/ARHP Poster Session C 1804. Eff
- Page 263 and 264:
ACR/ARHP Poster Session C Immunolog
- Page 265 and 266:
ACR/ARHP Poster Session C 2 Departm
- Page 267 and 268:
ACR/ARHP Poster Session C CA, 29 Un
- Page 269 and 270:
ACR/ARHP Poster Session C 1900. IL-
- Page 271 and 272:
ACR/ARHP Poster Session C 1930. Cor
- Page 273 and 274:
ACR/ARHP Poster Session C 1958. The
- Page 275 and 276:
ACR/ARHP Poster Session C 1988. Cha
- Page 277 and 278:
ACR/ARHP Poster Session C 2015. CpG
- Page 279 and 280:
ACR/ARHP Poster Session C 2038. Pri
- Page 281 and 282:
ACR/ARHP Poster Session C 2070. Ass
- Page 283 and 284:
REF Industry Roundtable-supported S
- Page 285 and 286:
REF Industry Roundtable-supported S
- Page 287 and 288:
INDUSTRY-SUPPORTED POST-CONFERENCE
- Page 289 and 290:
2010 ACR/ARHP Annual Meeting Leader
- Page 291 and 292:
2010 ACR/ARHP Annual Meeting Leader
- Page 293 and 294: FLOOR PLANS 2010 Program Book 291
- Page 295 and 296: VISIT THE EXHIBIT HALL New and inno
- Page 297 and 298: EXHIBITORS La Lettre Du Rhumatologu
- Page 299 and 300: ACKNOWLEDGEMENTS The ACR, the ARHP
- Page 301 and 302: ACR/ARHP/REF STAFF LISTING Administ
- Page 303 and 304: A Ahmed, Rafi, PhD T cell Memory .
- Page 305 and 306: Cooper, Max D, MD Introduction . .
- Page 307 and 308: Gerlag, Danielle Marie, MD, PhD The
- Page 309 and 310: Physical Examination Skills for Imp
- Page 311 and 312: Meroni, Pierluigi, MD Autoantibodie
- Page 313 and 314: Rogers, Joan C, PhD, OTR/ L Underst
- Page 315 and 316: Terkeltaub, Robert, MD Crystallizin
- Page 317 and 318: A Aarden, L 1825 Aarrass, S 1519, 1
- Page 319 and 320: Bakker, AAB 1095 Barendregt, B 753
- Page 321 and 322: Boutin-Le Thi Huong, D 478 Bout-Tab
- Page 323 and 324: Chatham, WW 457, 1146, 1454, 1457,
- Page 325 and 326: Daudon, M 875 Daugas, E 2009 Davatc
- Page 327 and 328: Ehst, B 758 Eicher, JL 688 Eisen, S
- Page 329 and 330: Gabay, OH 1484 Gaber, T 630, 1418 G
- Page 331 and 332: Guan, M 965 Guañabens, N 975 Gudbj
- Page 333 and 334: Homme, CL 730 Honda, E 434 Hong, JY
- Page 335 and 336: Kambayashi, T 1354 Kamdar, AA 1160
- Page 337 and 338: Kuller, LH 71 Kumabe, M 1164 Kumaga
- Page 339 and 340: Looney, C 941 Looney, MR 609 Looney
- Page 341 and 342: McCarthy, GM 1109, 1306, 1426 McCau
- Page 343: Myouzen, K 1577 Mysiw, WJ 2096 Mysl
- Page 347 and 348: Radka, S 1174 Radner, H 296, 1745 R
- Page 349 and 350: Sack, KE 1898 Sacli, SF 1312 Saddic
- Page 351 and 352: 1463, 2071, 2140, 2141 Singh, K 212
- Page 353 and 354: Takahata, M 1492 Takasaki, Y 1731 T
- Page 355 and 356: 636 van Dongen, CJJ 90 Van Doornum,
- Page 357 and 358: Witte, T 824, 1578, 1579, 2214 Witt
- Page 359 and 360: A α-galactosylceramide 505 A2A kno
- Page 361 and 362: Behcet’s syndrome 1284, 1288, 129
- Page 363 and 364: cost-utility 759, 1539 couples 1324
- Page 365 and 366: fibroblast like synoviocyte 27 fibr
- Page 367 and 368: impact 1063, 1325 inactive disease
- Page 369 and 370: methylation 826, 1253, 1489 methylt
- Page 371 and 372: 233, 234, 240, 243, 252, 262, 268,
- Page 373 and 374: 1599, 1600, 1603, 1605, 1606, 1609,
- Page 375 and 376: 1226, 1227, 1229, 1230, 1231, 1233,
- Page 377 and 378: Abelson, Abby Goulder, MD Education
- Page 379 and 380: Massarotti, Elena M, MD Systemic Lu
- Page 381 and 382: ACR Annual Meeting fellowS-in-train
- Page 383 and 384: NOTES 2010 Program Book 381
- Page 385 and 386: Enbrel ® (etanercept) Brief Summar
- Page 387 and 388: Prescription Enbrel ® (etanercept)
Change language